In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice.
暂无分享,去创建一个
Noriaki Ohuchi | Hideo Higuchi | N. Ohuchi | H. Higuchi | H. Tada | Hiroshi Tada | Tomonobu M Wanatabe
[1] A. Santoro,et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] C. Benz,et al. Emerging antibody-based HER2 (ErbB-2/neu) therapeutics. , 2000, Breast disease.
[3] K. Fujimoto-Ouchi,et al. Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5′-dFUrd in human breast cancer models , 2002, Cancer Chemotherapy and Pharmacology.
[4] Paul R. Selvin,et al. Myosin V Walks Hand-Over-Hand: Single Fluorophore Imaging with 1.5-nm Localization , 2003, Science.
[5] Philippe Rostaing,et al. Diffusion Dynamics of Glycine Receptors Revealed by Single-Quantum Dot Tracking , 2003, Science.
[6] H. Higuchi,et al. Motility of myosin V regulated by the dissociation of single calmodulin , 2005, Nature Structural &Molecular Biology.
[7] M. Kurosumi,et al. Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6 , 1999, British Journal of Cancer.
[8] H. Higuchi,et al. A mutant of the motor protein kinesin that moves in both directions on microtubules , 2000, Nature.
[9] Vladimir P. Torchilin,et al. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] A. Kamal,et al. Connecting vesicle transport to the cytoskeleton. , 2000, Current opinion in cell biology.
[11] M. Bruchez,et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots , 2003, Nature Biotechnology.
[12] S. Lyons. Advances in imaging mouse tumour models in vivo , 2005, The Journal of pathology.
[13] R. Braun,et al. Hemodynamic parameters in blood vessels in choroidal melanoma xenografts and rat choroid. , 2002, Investigative ophthalmology & visual science.
[14] Donal J. Denvir,et al. Optimization of spinning disk confocal microscopy: synchronization with the ultra-sensitive EMCCD , 2004, SPIE BiOS.
[15] C. A. Carraway,et al. Association of the Ras to Mitogen-activated Protein Kinase Signal Transduction Pathway with Microfilaments , 1999, The Journal of Biological Chemistry.
[16] Hiroto Tanaka,et al. Simultaneous Observation of Individual ATPase and Mechanical Events by a Single Myosin Molecule during Interaction with Actin , 1998, Cell.
[17] E. Balcerczak,et al. Uptake of radiolabelled herceptin by experimental mammary adenocarcinoma. , 2003, Nuclear medicine review. Central & Eastern Europe.
[18] C. Mamot,et al. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. , 2005, Cancer research.
[19] J. Drevs,et al. Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study , 2004, Cancer Chemotherapy and Pharmacology.
[20] T. Hasson,et al. Uncoated endocytic vesicles require the unconventional myosin, Myo6, for rapid transport through actin barriers. , 2004, Molecular biology of the cell.
[21] J. Luzio,et al. Myosin VI isoform localized to clathrin‐coated vesicles with a role in clathrin‐mediated endocytosis , 2001, The EMBO journal.
[22] Y. Nakanishi,et al. Antitumor effect of MCC‐465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts , 2004, Cancer science.
[23] H. Higuchi,et al. Single-molecule imaging of cooperative assembly of gamma-hemolysin on erythrocyte membranes. , 2003, The EMBO journal.
[24] U. Nielsen,et al. Tumor targeting using anti-her2 immunoliposomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[25] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[26] R. Jain,et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. , 1992, Cancer research.
[27] J. Post,et al. Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction , 2004, Nature Biotechnology.
[28] D. Scheinberg,et al. Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids , 2004, Clinical Cancer Research.
[29] D. Balding,et al. HLA Sequence Polymorphism and the Origin of Humans , 2006 .